AIGR Deep Research Report — SSB1 (P11484), Saccharomyces cerevisiae

Focus type: core_function Seed hypothesis: "The four amino-acid differences between Ssb1 and Ssb2 confer a demonstrated paralog-specific substrate preference or cotranslational folding mechanism."

Executive Judgment

Verdict: REFUTED as stated (over-annotation of a redundant paralog pair).

The hypothesis has two clauses. The factual premise — that Ssb1 and Ssb2 differ by four amino acids — is correct (verified directly: 613 aa each, 99.35 % identical, exactly 4 substitutions). The functional claim — that these differences confer a demonstrated paralog-specific substrate preference or cotranslational folding mechanism — is not supported by any primary literature. Across foundational and contemporary studies, Ssb1 and Ssb2 are treated as a single functional entity ("Ssb", "Ssb1/2p"), are deleted together, and no study assigns a distinct substrate spectrum or folding mechanism to one paralog versus the other. Three of the four differences do lie in the substrate-binding domain (SBD), which makes a paralog-specific effect structurally conceivable, but positional plausibility is not demonstration. The word "demonstrated" is the failure point: there is no such demonstration.

Most important caveat: absence of evidence for divergence is not the same as proof of perfect functional identity; a subtle, condition-specific difference has not been rigorously excluded. But for GO curation purposes, any paralog-specific MF/BP term would be unsupported and should not be asserted.

Evidence Matrix

No competing paper asserting a demonstrated Ssb1-vs-Ssb2 functional difference was found.

GO Decision Table (grounded in current SSB1 annotations, QuickGO/P11484, verified Iteration 2)

SSB1 currently carries 39 GO annotations, none of which are paralog-specific. Representative terms and the recommended action relative to the seed hypothesis:

Key point: the IMP process terms derive from double-mutant (ssb1Δ ssb2Δ) phenotypes, i.e., they document the shared Ssb function, not a paralog-resolved one. No existing term encodes a paralog-specific activity, and none should be added.

GO Curation Implications (leads — require curator verification)

• Do NOT create or retain any paralog-specific MF/BP/CC term implying Ssb1 has a substrate preference or cotranslational mechanism distinct from Ssb2. Such a term would be an over-annotation.
• Appropriate, supported terms for SSB1 (shared with SSB2, evidence-backed):
• MF: unfolded protein binding (GO:0051082); ATP binding / ATP hydrolysis activity (Hsp70 NBD).
• BP: protein folding / 'de novo' cotranslational protein folding (GO:0051083 / GO:0140719); regulation of translation / translational fidelity context.
• CC: cytosol (GO:0005829); cytosolic ribosome / ribosome-associated (polysome association, GO:0022626-adjacent).
• Recommended action: retain the general ribosome-associated Hsp70 chaperone annotations; generalize/avoid any qualifier that ascribes a unique substrate class to Ssb1. If a paralog-specific annotation currently exists, flag it for removal or down-grading to NAS/non-core.
• Avoid "protein binding" (GO:0005515) as a final call; unfolded protein binding is the more informative supported MF.

Substitution Severity Analysis (computed, Iteration 3 — provenance: ssb1_ssb2_substitution_analysis.csv)

Physicochemical severity (Grantham distance) of the four Ssb1→Ssb2 substitutions:

Mean Grantham = 82.5. Interpretation: three of four differences are conservative/moderate — consistent with near-neutral divergence between redundant WGD paralogs. The single striking substitution is C435V, which removes the only paralog-distinguishing cysteine (a redox-active thiol) in Ssb1, located in the substrate-binding β-subdomain. This makes C435 the best candidate residue for any hypothetical functional difference (e.g., redox-sensitive substrate handling), yet it remains entirely untested — no experiment links it to a substrate preference. This nuance neither rescues the "demonstrated" claim nor is dismissible; it is a lead, not evidence.

Mechanistic Scope

• Immediate molecular function (both paralogs): an ATP-dependent Hsp70 chaperone that, in complex with the RAC co-chaperone (Zuo1/Ssz1), binds hydrophobic segments of nascent polypeptides at the ribosomal exit tunnel to promote cotranslational folding and prevent misfolding/aggregation. This is a shared activity.
• The tested increment — a paralog-specific substrate preference or a distinct folding mechanism for Ssb1 — is the piece with no direct gene-product evidence.
• Downstream/pleiotropic effects (not core function, and not paralog-specific): translational repression of poly-lysine/nonstop transcripts, premature termination, prion ([PSI+]) modulation, TORC1-linked translational control. These are collective RAC/Ssb-system phenotypes.

Conflicts and Alternatives

• Paralog confusion / carry-over is the central risk. SSB1 and SSB2 arose from the whole-genome duplication and remain ~99 % identical; databases and papers routinely collapse them to "Ssb". A curation asserting Ssb1-specific function would most likely be database carry-over / inference, not demonstrated fact.
• Alternative interpretation (best-supported): the 4 differences are evolutionarily tolerated near-neutral substitutions between redundant WGD paralogs, not adaptive functional divergence. The joint-deletion requirement for phenotypes (single deletions are near-silent) is classic redundancy.
• Residue-level nuance: C435V removes a cysteine unique to Ssb1 (potential redox/thiol difference) and M413I/A436S sit in the SBDβ — these could seed a testable hypothesis, but currently support only speculation, not a "demonstrated" claim.

Knowledge Gaps

1. Has any assay directly compared Ssb1-only vs Ssb2-only cells/proteins? Checked PubMed broadly; none found. Matters because it is the exact evidence the hypothesis claims exists. Resolve with paralog-swap strains + selective ribosome profiling (SeRP).
2. Do the 4 residues alter substrate contacts? Checked UniProt features — none are annotated substrate/nucleotide binding sites; three are merely within the SBD region. Resolve with structural modeling of the peptide-binding cleft and in vitro peptide-array affinity comparison.
3. Expression/regulatory divergence? Not resolved here; even if promoters differ, that would be regulatory, not the "substrate preference / folding mechanism" claimed. Resolve with paralog-specific expression datasets.

Discriminating Tests

• Selective ribosome profiling (SeRP) on FLAG-Ssb1-only vs FLAG-Ssb2-only strains (each in ssb1Δ ssb2Δ background) → directly tests differential nascent-chain substrate spectra.
• Reciprocal complementation: does SSB2 fully rescue ssb1Δ phenotypes and vice versa across stress panels? Full rescue = redundancy (refutes); a specific non-complemented phenotype = paralog-specific (would support).
• In vitro peptide-binding / ATPase kinetics of purified Ssb1 vs Ssb2 (and site-swap mutants at 49/413/435/436) → isolates the causal contribution of the 4 residues.
• Cys435 redox probe: test thiol-dependent behavior unique to Ssb1.

Curation Leads (verify before applying)

• Lead 1 — Reject paralog-specific functional annotation. No primary evidence supports a distinct Ssb1 substrate preference or mechanism; treat as over-annotation.
• Lead 2 — Candidate references to cite for shared function: 23332755 (SSB cotranslational substrate specificity, as one entity), 1394434 (Ssb1/2p ribosome association), 35701497 / 37081320 (RAC–Ssb cotranslational folding mechanism).
• Snippet to verify (23332755): "we use a sensitive and global approach to define the cotranslational substrate specificity of the yeast Hsp70 SSB."
• Snippet to verify (1394434): "The SSB hsp70s (Ssb1/2p) are associated with translating ribosomes."
• Lead 3 — Suggested curator question: Is any existing Ssb1-specific term backed by an experiment using an Ssb1-only reagent/strain, or is it inferred from the shared "Ssb" literature? If the latter, generalize the term to reflect shared function.
• Lead 4 — Suggested experiment (if lab-backed curation desired): paralog-swap SeRP (see Discriminating Tests).

Confidence

High confidence that the hypothesis is not demonstrated (verdict: refuted-as-stated / over-annotation). Moderate residual uncertainty that a subtle, untested paralog difference exists — relevant only if future experiments provide it; it should not drive current curation.